2022. MORTALITY AND ITS RISK FACTORS AMONG IN-PATIENTS WITH INVASIVE ASPERGILLOSIS TREATED WITH VORICONAZOLE. The Southeast Asian Journal of Tropical Medicine and Public Health. 53, 2 (Mar. 2022), 142–150.